Rozanolixizumab
Product Specifications
CAS Number
1584645-37-3
Target
Others|||TNF
Related Pathways
Apoptosis|||Others
Purity
0.972
Bioactivity
Rozanolixizumab (RYSTIGGO) is a high-affinity humanized immunoglobulin G4 monoclonal antibody targeting Fc receptors (FcRn) in human newborns for the study of pathogenic IgG in autoimmune and alloimmune diseases.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS9455853-01 0.1 mL (Biotin)
Cadherin EGF LAG Seven-Pass G-Type Receptor 2 Conjugated Antibody
Ask
View Details MBS9455853-02 0.1 mL (AF350)
Cadherin EGF LAG Seven-Pass G-Type Receptor 2 Conjugated Antibody
Ask
View Details 
MBS9455853-03 0.1 mL (AF405)
Cadherin EGF LAG Seven-Pass G-Type Receptor 2 Conjugated Antibody
Ask
View Details 
MBS9455853-04 0.1 mL (AF488)
Cadherin EGF LAG Seven-Pass G-Type Receptor 2 Conjugated Antibody
Ask
View Details MBS9455853-05 0.1 mL (AF555)
Cadherin EGF LAG Seven-Pass G-Type Receptor 2 Conjugated Antibody
Ask
View Details MBS9455853-06 0.1 mL (AF594)
Cadherin EGF LAG Seven-Pass G-Type Receptor 2 Conjugated Antibody
Ask
View Details